CAPRICOR THERAPEUTICS
Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Its CAP-1002 is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and COVID-19. The company was founded in 2005 and is headquartered in Los Angeles, California.
CAPRICOR THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.capricor.com
Total Employee:
11+
Status:
Active
Contact:
(310) 358-3200
Email Addresses:
[email protected]
Total Funding:
66.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nucleonics
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
![]()
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
![]()
Current Employees Featured
![]()
Founder
![]()
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Capricor Therapeutics
![]()
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Capricor Therapeutics
![]()
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Capricor Therapeutics
Cedars Sinai
Cedars Sinai investment in Post-IPO Equity - Capricor Therapeutics
![]()
CureDuchenne Ventures
CureDuchenne Ventures investment in Post-IPO Equity - Capricor Therapeutics
![]()
Broadview Ventures
Broadview Ventures investment in Post-IPO Equity - Capricor Therapeutics
![]()
Calmedica
Calmedica investment in Post-IPO Equity - Capricor Therapeutics
![]()
Beechwood Ventures
Beechwood Ventures investment in Post-IPO Equity - Capricor Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-02 | Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development |
Official Site Inspections
http://www.capricor.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.98 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
